insights_auto
Bakit tumaas ang NVZMF 6.12%?
Tingnan ang Higit pang Detalyechevron_right
NVZMF:OTCMKTS
Novozymes A/S
$69.35
arrow_upward
+6.12%(+4.00) 1D
Okt 15, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa NVZMF...
Buksan
$69.26
Mataas
$69.35
Mababa
$69.20
Mkt. cap
183.47B
Avg. na dami
550.00
Dami
368.00
Mataas nang 52-wk
$72.98
Mababa nang 52-wk
$52.10
Beta
0.82
Mga natitirang share
414.56M
Bilang ng mga empleyado
11K
Buksan
$69.26
Mataas
$69.35
Mababa
$69.20
Mkt. cap
183.47B
Avg. na dami
550.00
Dami
368.00
Mataas nang 52-wk
$72.98
Mababa nang 52-wk
$52.10
Beta
0.82
Mga natitirang share
414.56M
Bilang ng mga empleyado
11K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
23 oras ang nakalipas
Novonesis stock stands 1.27 percent below its 52-week high
Profile
Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia
Tungkol sa Novozymes A/S
CEOEster Baiget
Mga Empleyado11.1K
Itinatag2000
Headquarters-
SektorSpeciality chemicals
Websitenovonesis.com